0.36 USD
▼-0.02-5.81%
盘后 0.74 0.00%
2026-11-20
市值
$57.15M
市盈率
0.95
EPS
-0.96
股息率
—
52 周区间
0.36 – 2.62
成交量
1.85M
Beta
1.05
目标价
7.25
52W 低 0.3652W 高 2.62
价格走势
公司简介
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin IL-27. It also develops CHS-114, an investigational human afucosylated IgG1 monoclonal antibo...